Edwards receives FDA approval for mitral valve replacement system
The TMVR procedure with SAPIEN M3 involves dock and valve delivery via a percutaneous femoral vein guide sheath.
Medical Devices
Fulgent Genetics to buy Bako Diagnostics assets and StrataDx
FDA approves Abbott’s Volt PFA system for atrial fibrillation
Neurable secures $35m to expedite BCI technology commercialisation
ZOLL introduces next-gen wearable cardioverter defibrillator in US
Curasight doses first patient in Phase I brain cancer trial of uTREAT
Abbott secures FDA and CE Mark approvals for Amplatzer delivery system
MARAbio introduces MAR-Autism Test to detect maternal autoantibodies
